Destinie Smith's Contact Details

Destinie Smith's Company Details

CardioNet was just the beginning. Founded on an innovative, patented technology, the result of years of research and development, the company received FDA approval for its core monitoring technology and was the first to provide real-time, heartbeat-by-heartbeat, ECG monitoring, analysis and response, at home or away, 24/7/365.BioTelemetry Healthcare is focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders. The Company provides cardiologists and electrophysiologists who prefer to use a single source of cardiac monitoring services with a full spectrum of solutions, ranging from the differentiated Mobile Cardiac Outpatient Telemetry™ ("MCOT™") service to wEvent, event, Holter, Pacemaker and International normalized ratio ("INR") monitoring. INR monitoring is a measurement of blood coagulation in the circulatory system and is prescribed for patients on long term anticoagulation therapy.